Professor William Alazawi, MA(Cantab) MB BChir PhD FRCP
Professor of Hepatology; Director of Research
Centre: Immunobiology
Email: w.alazawi@qmul.ac.uk
Telephone: 020 7882 2308
Twitter: @willalazawi
Profile
Professor Alazawi graduated from the MB/PhD Programme in Cambridge in 2003. He conducted his doctorate research in Professor Coleman’s laboratory at the MRC Cancer Cell Unit where he studied host-viral interactions in pre-malignant disease. He moved to London to work with Professor Graham Foster where he conducted further studies into innate immune signalling, becoming an NIHR Clinical Lecturer in 2011.
He established his own group in 2013 focusing on Non-Alcoholic Fatty Liver Disease and its progressive fibroinflammatory form, Non-Alcoholic Steatohepatitis or NASH for short. His MRC-funded basic science laboratory team studies immune and metabolic signalling with current focus on single cell techniques, multiorgan inflammation and metabolism. Professor Alazawi also leads a translational programme of research, studying the epidemiology and natural history of NASH, the diagnostic pathways including the management of abnormal liver tests and novel therapies for NASH. He has won a number of prestigious awards including an Academy of Medical Sciences Starter Grant, the Physician Scientist Fellowship of the European Association for the Liver and a New Investigator Award from the Medical Research Council
He is the NIHR Integrated Academic Training Programme Co-Lead at QMUL, Blizard Institute Lead for Research Impact and Clinical Lead for NAFLD at Barts Health. He is the Chair of the BASL Special Interest Group for NAFLD, a member of the Clinical Advisory Group for the British Liver Trust and Head of Research for LAP Research – a UK charity that focuses on liver and pancreatic disease.
Summary
Centre: Immunobiology.